Linden Collins, MD
Obstetrics & Gynecology · Kansas City, KSNPI 1164684890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $889, 2.2 times the $399 reported in 2019.
Across 207 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$747
- Sumitomo Pharma America, Inc.$525
- Organon$461
- Pfizer$326
- Astellas Pharma US Inc$297
- Mayne Pharma Commercial LLC$258
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,161100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $747 |
| Sumitomo Pharma America, Inc. | 24 | $525 |
| Organon | 21 | $461 |
| Pfizer | 16 | $326 |
| Astellas Pharma US Inc | 14 | $297 |
| Mayne Pharma Commercial LLC | 11 | $258 |
| Exeltis, USA Inc. | 13 | $218 |
| Coopersurgical, Inc. | 8 | $134 |
| Channel Medsystems, Inc. | 2 | $134 |
| Myovant Sciences Inc. | 7 | $131 |
| Hologic Sales And Service, LLC | 2 | $118 |
| Shield Therapeutics Inc | 3 | $110 |
| Therapeuticsmd, Inc. | 6 | $92 |
| Merck | 7 | $86 |
| Bayer | 4 | $81 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Avion Pharmaceuticals | 3 | $47 |
| Virtus Pharmaceuticals LLC | 2 | $41 |
| Dilon Technologies, Inc. | 1 | $39 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Sage Therapeutics, LLC | 2 | $32 |
| Meditrina | 2 | $28 |
| Exact Sciences | 1 | $24 |
| Scynexis, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Millicent US Inc | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $14 |
| Aspira Women's Health Inc | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Lupin Inc. | 1 | $13 |
| Bolder Surgical LLC | 1 | $7 |
How this compares
$4,175 in reported general payments places this provider in the 85th percentile of 302 obstetrics & gynecology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 39 | $2,744 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kansas City
- Austin FindleyKansas City$18K
- Madhuri ReddyKansas City$13K
- Melanie MeisterKansas City$6K
- Erin CareyKansas City$6K
- Meredith GrayKansas City$6K
- Sherebanu GaslightwalaKansas City$3K
- Kristi Weaver RoweKansas City$3K
- Kimberly SwanOverland Park$123K
- Michael FenechPittsburg$65K
- Michael MageeShawnee Mission$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.